VBIO

Vitality Biopharma, Inc.

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 6/20/2017
Contact Info
  • 1901 Avenue of the Stars
  • 2nd Floor
  • Los Angeles, CA 90067

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Jun 30, 2017 10-Q
CIK 0001438943
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 8731 - Commercial physical research
Incorporated In: NV, USA
Year of Inc. 2007
Employees 7 a/o Jul 21, 2016
Company Officers/Contacts
Robert Brooke CEO
Richard McKilligan Counsel, Controller, Corporate Secretary
Company Directors
Avtar Dhillon Chairman
Robert Brooke
Anthony E. Maida
Service Providers
Accounting/Auditing Firm
Weinberg & Company
1925 Century Park E.
Suite 1120
Los Angeles, CA, 90067
United States
 
Securities Counsel
Greenberg Traurig LLP OTCQX Sponsor
1201 K Street
Suite 1100
Sacramento, CA, 95814
United States
 
Morrison & Foerster LLP
1925 Century Park East
Suite 1120
Los Angeles, CA, 90067
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=Stevia First Corp. until 7-2016
  • Formerly=Legend Mining, Inc. until 10-2011
VBIO Security Details
Share Structure
Market Value1 $33,604,558 a/o Oct 20, 2017
Authorized Shares 1,000,000,000 a/o Oct 13, 2017
Outstanding Shares 21,404,177 a/o Oct 13, 2017
-Restricted 3,423,068 a/o Oct 13, 2017
-Unrestricted 17,981,109 a/o Oct 13, 2017
Held at DTC 17,254,748 a/o Oct 13, 2017
Float 18,466,590 a/o May 31, 2017
Par Value Not Available
Transfer Agent(s) Verified by Transfer Agent
Island Stock Transfer
Shareholders
Shareholders of Record 31 a/o Jun 28, 2017
Short Selling Data
Short Interest 187,886 (-8.38%)
Sep 29, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security